Michael Kirschner of Kirschner Intellectual Property Law & Consulting, PLLC, is ideally situated to assist any company, foreign or American, who wishes to assess and/or mitigate IP risks in the United States market, assert or defend against patents in the U.S. market alone or in conjunction with patent litigation in other jurisdictions, or otherwise have strategic or tactical concerns about U.S. patents. He can serve as a virtual head of IP for companies that do not have an internal head or he can work with internal IP attorneys in assisting with the maximizing the likelihood of success in achieving corporate goals, whether through litigation or by other means.His experience includes over 25 years of experience in U.S. and foreign patent litigation, including work both in-house at corporations and at outside law firms, supervisory responsibility for acquiring and protecting intellectual property for corporations, and the obligation to assess freedom to operate and threats from third party patent owners.

Continued oversight of Baxalta legacy litigation matters.

Following the spin-off of Baxalta from Baxter, was requested to create and assume the role to develop and execute intellectual property litigation strategy for a company highly dependent upon international patent litigation outcomes. Responsible for worldwide intellectual property litigation and opposition issues including threat identification, assessment, and mitigation; U.S. and foreign litigation; International Trade Commission (ITC) investigations; foreign patent oppositions; reexaminations and inter partes reviews (IPRs) at the United States Patent and Trademark Office.

Supervised the biotechnology division of IP attorneys with direct reports in Illinois, California, Germany, and Austria. Guided and educated direct reports on all aspects of worldwide intellectual property issues including patent procurement; landscape reviews; threat identification, assessment, and mitigation; evaluation of business development opportunities; U.S. and foreign litigation; ITC investigations; oppositions; reexaminations; IPRs; and opinions relating to patents and trade secrets.

Patent attorney specializing in patent litigation, patent licensing, and strategic and tactical patent counseling including patent portfolio development, freedom-to-operate analyses, invalidity opinions, non-infringement opinions, patent prosecution, patent appeals, reexaminations, and oppositions.

Patent attorney specializing in patent litigation, patent licensing, and strategic and tactical patent counseling including patent portfolio development, freedom-to-operate analyses, invalidity opinions, non-infringement opinions, patent prosecution, patent appeals, reexaminations, and oppositions.

Patent attorney specializing in patent litigation, patent licensing, and strategic and tactical patent counseling including patent portfolio development, freedom-to-operate analyses, invalidity opinions, non-infringement opinions, patent prosecution, patent appeals, reexaminations, and oppositions.

Head of Amgen’s Seattle law office. Oversaw integration of the Immunex patent group into the Amgen law department. Supervised Amgen patent attorneys and staff located in Seattle. Handled strategic issues relating to ENBREL® (etanercept). Oversaw ENBREL litigation and licensing negotiations.

Managed patent attorneys, agents, and staff of 20 in the Immunex Intellectual Property (“IP”) law group. Supervised all aspects of patent application drafting, U.S. prosecution, foreign prosecution, and post-grant issues, including reexaminations, reissues, and oppositions. Responsible for trademarks, copyrights, and maintenance of trade secrets. Personally responsible for third-party intellectual property issues relating to ENBREL, including patent licensing. Personally responsible for patent and trademark litigation.

Handled biotechnology and electrical patent and trade secret disputes in arbitration, U.S. federal court, the U.S. International Trade Commission, and U.S patent interference proceedings. Drafted and prosecuted applications in the biotechnology, pharmaceutical and chemical arts.PRIOR EXPERIENCE: CADES, SCHUTTE, FLEMING & WRIGHT, Honolulu, HI, Associate Attorney UNITED STATES NAVY, Washington, DC, JAG Corps Attorney Head prosecutor for Naval District Washington, encompassing DC, MD, and Northern VA, including the U.S. Naval Academy, the Pentagon, and Bethesda Naval Hospital. Clerk for the Navy-Marine Corps Court of Military Review. Defense counsel. Regional Physical Evaluation Board Counsel.MAYO CLINIC, Rochester, MN, Research Assistant Research into glucocorticoid receptors under supervision of Dr. Kristin M. Leiferman in laboratory of Dr. Thomas C. Spelsberg.SIDNEY FARBER CANCER INSTITUTE (now the Dana Farber Cancer Institute), Boston, MA, Research AssistantHerpes simplex virus genetic research in laboratory of Dr. Priscilla A. Schaeffer.